|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||
| Total Current Assets | ||||||||||||||
| Total Assets | ||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||
| Due to related party | ||||||||||||||
| Total Current Liabilities | ||||||||||||||
| Total Liabilities | ||||||||||||||
| Preferred Stock Series D, $0.001 par value; 10,000,000 shares authorized, 300,000 and 300,000 shares issued and outstanding, respectively | ||||||||||||||
| Total preferred Stock Series D, $0.001 par value; 10,000,000 shares authorized, 300,000 and 300,000 shares issued and outstanding, respectively | ||||||||||||||
| Common Stock, $0.001 par value; 500,000,000 shares authorized, 454,365 and 454,365 shares issued and outstanding, respectively | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Accumulated loss | ||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||
| Total Liabilities and Stockholders’ Deficit | ||||||||||||||
Loading...
